Encentrio Therapeutics, Inc.

About Encentrio Therapeutics

Encentrio Therapeutics is a private company based in San Francisco, California, incorporated in 2023 in Delaware. It has reported $400,000 raised in one offering on Form D since April 2023. Its chief executive is Natascha Schill.

Funding Rounds (SEC Form D)

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Encentrio Therapeutics's Form D filed Apr 3, 2023.

Largest Form D Raises Filed the Same Day

Private companies with new Form D filings accepted by the SEC on Apr 3, 2023.

Sources

1. SECEncentrio Therapeutics, Inc. filing history